Voximetry

Voximetry provides advanced dosimetry software and clinical services for radiopharmaceutical therapy (RPT), enabling personalized cancer treatment guidance. The company addresses significant variability in patient response to RPT (up to 10-fold differences) through GPU-accelerated dose assessment technology and expert dosimetry services. Voximetry offers three primary service lines: (1) Torch®, a proprietary software platform for analyzing nuclear medicine scans to calculate patient-specific pharmacokinetics and radiation dose estimates to tumors and critical organs; (2) Advanced Dosimetry Services for clinical use, delivered as a managed service to minimize capital expenditure and IT complexity for healthcare providers; and (3) Dosimetry Services for RPT clinical trials, supporting researchers and contract research organizations in meeting trial dosimetry requirements without in-house deployment. The company targets oncology departments, nuclear medicine clinics, academic medical centers, and pharmaceutical companies conducting RPT development. Voximetry operates as a software-as-a-service and laboratory service provider, positioning itself to routinize sophisticated patient-specific dosimetry in clinical practice and clinical research. The organization has partnered with major CROs (e.g., Medpace) and received recognition as a finalist for the 2025 Siemens Healthineers Startup Award.